InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: misiu143 post# 36742

Tuesday, 02/19/2019 12:07:14 AM

Tuesday, February 19, 2019 12:07:14 AM

Post# of 232883
The reason why is because the cancer study is technically a phase 1/2 study. Phase 1 studies are normally in place to test out safety. Of course, as we know the safety of leronlimab does not need to be tested yet again. Therefore, any other indications can go straight to a phase 1/2 and if positive results are achieved can go straight to a phase 3 program.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News